Home Cart Sign in  
Chemical Structure| 41575-94-4 Chemical Structure| 41575-94-4

Structure of Carboplatin
CAS No.: 41575-94-4

Chemical Structure| 41575-94-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Carboplatin (NSC 241240) functions as a DNA synthesis inhibitor by binding to DNA, thereby impeding replication and transcription processes, ultimately leading to cell death. Derived from CDDP, Carboplatin (NSC 241240) emerges as a potent anti-cancer agent.

Synonyms: NSC 241240; CBDCA; Ribocarbo

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Carboplatin

CAS No. :41575-94-4
Formula : C6H12N2O4Pt
M.W : 371.25
SMILES Code : O=C1C2(CCC2)C(O[Pt]O1)=O.N.N
Synonyms :
NSC 241240; CBDCA; Ribocarbo
MDL No. :MFCD00070464
InChI Key :VSRXQHXAPYXROS-UHFFFAOYSA-N
Pubchem ID :426756

Safety of Carboplatin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302+H312+H332-H317-H361
Precautionary Statements:P201-P202-P261-P264-P270-P271-P272-P280-P284-P301+P312+P330-P302+P352+P312-P304+P340+P312-P308+P313-P333+P313-P405-P501

Related Pathways of Carboplatin

DNA

Isoform Comparison

Biological Activity

Target
  • DNA synthesis

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05490407 Gynecologic Cancer|Ovarian Can... More >>cer|High Grade Serous Carcinoma|Chemotherapy Effect Less << COMPLETED 2024-01-01 Department of Gynecology, Divi... More >>sion of Gynecology and Obstetrics, Ljubljana University Medical Center, Ljubljana, 1000, Slovenia|Institute of Pharmacology and Experimental Toxicology, Faculty of Medicine, University of Ljubljana., Ljubljana, Slovenia Less <<
NCT02035345 Recurrent Ovarian Cancer|Plati... More >>num Sensitive Ovarian Cancer Less << PHASE4 TERMINATED 2025-06-16 Massachusetts General Hospital... More >>, Boston, Massachusetts, 02215, United States Less <<
NCT00145028 Neoplasms COMPLETED 2025-02-09 Centre Paul Papin, Angers, Fra... More >>nce|Institut Bergonié, Bordeaux, France|Clinique Pasteur, Evreux, France|CHU A. Michallon, Grenoble, France|Centre Oscar Lambert, Lille, France|CHU de la Timone, Marseille, France|Centre Val d'Aurelle, Montpellier, France|Centre Antoine Lacassagne, Nice, France|CHU de N?mes, N?mes, France|Hopital Européen Georges Pompidou, Paris, France|Clinique Mathilde, Rouen, France|Centre René Gauducheau, Saint Herblain (Nantes), France|CHU de Toulouse Rangueil, Toulouse, France|Institut Claudius Regaud, Toulouse, France|CHRU Bretonneau, Tours, France Less <<
NCT02734069 Lung Cancer|Sarcopenia|Toxicit... More >>y Less << RECRUITING 2025-12-25 Instituto Nacional de Cancerol... More >>ogia, Mexico City, 14080, Mexico Less <<
NCT02311764 Prostatic Neoplasm PHASE2 TERMINATED 2025-12-19 Cantonal Hospital Chur, Chur, ... More >>Graubuenden, 7000, Switzerland|Luzern Cantonal Hospital, Luzern, Switzerland|Cantonal Hospital St.Gallen, St.Gallen, 9007, Switzerland Less <<
NCT02339753 Pediatric Solid Tumor PHASE2 UNKNOWN 2025-12-16 Seoul National University Hosp... More >>ital, Seoul, Korea, Republic of Less <<
NCT02103244 Cancer PHASE4 UNKNOWN 2025-12-15 Rijnstate Hospital, Arnhem, 68... More >>15 AD, Netherlands Less <<
NCT02735057 Oesophagus Cancer|Elderly Pati... More >>ents Less << PHASE1|PHASE2 RECRUITING 2029-05-16 Centre Hospitalier Universitai... More >>re de Besan?on, Besancon, 25000, France Less <<
NCT02955082 Hormone Refractory Prostate Ca... More >>ncer Less << PHASE2 RECRUITING 2025-09-30 Institute of Cancer Research a... More >>nd Royal Marsden Hospital, Sutton, Surrey, SM2 5PT, United Kingdom Less <<
NCT01088035 Ependymoma PHASE2 TERMINATED 2025-04-15 Children's Memorial Hospital, ... More >>Chicago, Illinois, 60614, United States Less <<
NCT03652493 Castration-resistant Prostate ... More >>Cancer|Metastasis Less << PHASE2 TERMINATED 2021-04-27 Centre Fran?ois Baclesse, Caen... More >>, 14076, France|Centre Oscar Lambret, Lille, 59000, France|Chu Rouen, Rouen, 76000, France|Institut Gustave ROUSSy IGR, Villejuif, France Less <<
NCT05080556 Ovarian Cancer|Relapsed Ovaria... More >>n Cancer|Fallopian Tube Cancer|Peritoneal Cancer|Endometrioid Carcinoma|High Grade Serous Carcinoma|Ovary Cancer Less << PHASE2 RECRUITING 2027-11-01 University College London Hosp... More >>itals, London, United Kingdom Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.69mL

0.54mL

0.27mL

13.47mL

2.69mL

1.35mL

26.94mL

5.39mL

2.69mL

References

 

Historical Records

Categories